Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$10.12 - $23.32 $106,259 - $244,860
10,500 Added 9.01%
126,978 $1.52 Million
Q1 2022

May 12, 2022

BUY
$19.54 - $33.59 $870,741 - $1.5 Million
44,562 Added 61.96%
116,478 $2.49 Million
Q4 2021

Feb 10, 2022

BUY
$22.51 - $36.79 $168,262 - $275,005
7,475 Added 11.6%
71,916 $2.42 Million
Q3 2021

Nov 12, 2021

BUY
$13.28 - $25.79 $106,439 - $206,706
8,015 Added 14.2%
64,441 $1.66 Million
Q2 2021

Aug 11, 2021

SELL
$10.5 - $14.19 $35,752 - $48,316
-3,405 Reduced 5.69%
56,426 $755,000
Q1 2021

May 11, 2021

SELL
$8.2 - $14.49 $8,273 - $14,620
-1,009 Reduced 1.66%
59,831 $635,000
Q4 2020

Feb 11, 2021

SELL
$6.87 - $8.88 $8,298 - $10,727
-1,208 Reduced 1.95%
60,840 $489,000
Q3 2020

Nov 09, 2020

BUY
$7.48 - $9.54 $220,861 - $281,687
29,527 Added 90.79%
62,048 $464,000
Q2 2020

Aug 12, 2020

BUY
$8.64 - $11.87 $210,755 - $289,544
24,393 Added 300.11%
32,521 $293,000
Q1 2020

May 11, 2020

BUY
$9.11 - $14.42 $60,326 - $95,489
6,622 Added 439.71%
8,128 $79,000
Q4 2019

Feb 06, 2020

BUY
$13.16 - $15.96 $19,818 - $24,035
1,506 New
1,506 $21,000
Q4 2018

Feb 07, 2019

SELL
$13.84 - $18.79 $34,184 - $46,411
-2,470 Closed
0 $0
Q3 2018

Oct 30, 2018

SELL
$12.89 - $23.43 $50,889 - $92,501
-3,948 Reduced 61.51%
2,470 $44,000
Q2 2018

Jul 24, 2018

SELL
$14.31 - $20.59 $52,932 - $76,162
-3,699 Reduced 36.56%
6,418 $92,000
Q1 2018

Apr 12, 2018

BUY
$18.8 - $26.5 $47,752 - $67,310
2,540 Added 33.52%
10,117 $194,000
Q4 2017

Jan 18, 2018

BUY
$18.16 - $40.15 $137,598 - $304,216
7,577
7,577 $174,000

Others Institutions Holding OPNT

About OPIANT PHARMACEUTICALS, INC.


  • Ticker OPNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,164,150
  • Description
  • Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...
More about OPNT
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.